The co-occurrence of BRCA1 loss and TAZ gain may represent a genetic feature of basal-like breast tumors and may provide a rationale for the aggressiveness of BRCA1 mutated tumors, where inactivation of the BRCA1 tumor suppressor may also have the effect of activating the TAZ oncogenic program. This evidence concerns the gene BRCA1 and neoplasm.